Polypoidal Choroidal
Vasculopathy
Dr. Md Mominul Islam
Fellow Vitreo - Retina
Introduction
 PCV is an exudative maculopathy with features similar
to neovascular AMD with hemorrhage, pigment
epitheliu...
History
• In 1982 By Yannuzzi et al
• At annual meeting of American academy of
ophthalmology as :-
 Polypoidal , subretin...
History (contd) In 1984 Kleiner et al Described as:-
 A peculiar hemorrhagic disorder of the macula and
sub retinal pigm...
Pathogenesis
 It is a primary abnormality of the choroidal
circulation, characterized by :-
 An inner choroidal vascular...
Histopathological Features
 Kuroiwa reported from surgically excised specimens
from 5 patients with PCV had been diagnose...
Histopathological Features (Contd)
In another histopathologic group :
• Nakashizuka et al, who also examined from surgical...
Immuno ChemistryThis group demonstrated that :
• PCV is not the same as choroidal neovascularization.
• CD-34 is a marker ...
Demography
Prevalence of PCV in presumed neovascular AMD
• US -7.8%
• Belgian – 4.0%
• Italian - 9.8 %
• Greek – 8.2%
• Ja...
Demography (contd)
 Varies with age
 Predominantly middle aged ,one or two decade earlier
than classical AMD
 Commonly ...
Course
Natural course of disease is Variable:-
 May be relatively stable
 May repeated bleeding and leakage with vision ...
Clinical feature Usually bilateral
 Protruding orange –red elevated lesion often with
nodular elevations of RPE.
 Also ...
Clinical feature (contd)
Location of the lesion:
 In the macular area -69.5%
 Under the temporal retinal vascular arcade...
Clinical feature (contd)Lesions may active or inactive.
• Lesions considered as active on the evidence of
clinical, OCT, F...
ICGA :-
• Accepted as the gold standared for diagnosis of PCV.
• Better visualization in ICGA than FFA
 ICG absorbs and
e...
Characteristics feature of PCV in ICGA:-
 A branching network of inner choroidal vessels.
 Nodular polypoidal aneurysm o...
Classification
According to Japanese group on PCV
Quiescent: Polyps in the absence of subretinal or intraretinal fluid
or ...
Differential Diagnosis
 AMD
 CSCR
Treatment
Thermal laser Photocoagulation:
To be beneficial ,albeit it with short term follow up
and for extra foveal lesio...
Photodynamic therapy:
 Regression or resolution of the polyp by in angio
occlusive mechanism of action
 Restrict loss of...
Anti VEGF therapy:
 Intravitreal Ranibizumab resolving the macular
oedema, polypoidal complexes decreased in 4/12 (33%)
e...
Combination therapy:
 Both combination therapy and vertiporfin PDT
monotherapy superior to ranibizumab monotherapy
in ach...
THANK YOU
Polypoidal Choroidal
Polypoidal Choroidal
Polypoidal Choroidal
Polypoidal Choroidal
of 27

Polypoidal Choroidal

Published on: Mar 4, 2016
Published in: Education      
Source: www.slideshare.net


Transcripts - Polypoidal Choroidal

  • 1. Polypoidal Choroidal Vasculopathy Dr. Md Mominul Islam Fellow Vitreo - Retina
  • 2. Introduction  PCV is an exudative maculopathy with features similar to neovascular AMD with hemorrhage, pigment epithelium detachment and neurosensory detachment.  Pathogenesis mostly unknown  It remains controverial as to weather PCV represents a sub type of neovascular AMD
  • 3. History • In 1982 By Yannuzzi et al • At annual meeting of American academy of ophthalmology as :-  Polypoidal , subretinal, vascular lesions associated with serous and hemorrhagic detachments of the RPE in a series of patients (10/11 patients were woman).  The entitity was initially called Idiopathic polypoidal choroidal vasculopathy.
  • 4. History (contd) In 1984 Kleiner et al Described as:-  A peculiar hemorrhagic disorder of the macula and sub retinal pigment epithelium bleeding in middle aged black woman ,which they term posterior uveal bleeding syndrome.  Later a study from the same group of authors showed an expanded clinical spectrum for PCV
  • 5. Pathogenesis  It is a primary abnormality of the choroidal circulation, characterized by :-  An inner choroidal vascular network of vessels ending in an aneurysmal bulged or outward projection often visible as a reddish – orange, spheroid ,polyp like structure.  PCV primarily involves the inner choroidal vasculature that is well differentiated from the middle and larger choroidal vessels by histology.
  • 6. Histopathological Features  Kuroiwa reported from surgically excised specimens from 5 patients with PCV had been diagnosed by ICGA :--  Results - arteriosclerosis appears to be an important pathological feature in the choroidal vessels of PCV subjects.
  • 7. Histopathological Features (Contd) In another histopathologic group : • Nakashizuka et al, who also examined from surgically excised specimens from 5 patients with PCV Results :- little granulation tissue from any of the specimens. On the other hand all the specimen exhibited:- • Massive exudative change and leaking ,all the vessels exhibited hyalinization and chorio-capillaris had disappeared ,in which RPE had been preserved.
  • 8. Immuno ChemistryThis group demonstrated that : • PCV is not the same as choroidal neovascularization. • CD-34 is a marker of vascular endothelial growth factor • CD-34 staining revealed  Discontinuity in the vascular endothelium.  Smooth muscle actin was negative in hyalinized vessels  There was disruption and injury of smooth cells causing dilation of vessels
  • 9. Demography Prevalence of PCV in presumed neovascular AMD • US -7.8% • Belgian – 4.0% • Italian - 9.8 % • Greek – 8.2% • Japanese – 23.0-54.7% • Chinese – 22.3% • Korean – 24.6%
  • 10. Demography (contd)  Varies with age  Predominantly middle aged ,one or two decade earlier than classical AMD  Commonly occur both gender ( more in Asian man than woman)  More prevalent in black, Japanese and other Asian than in white.  Incidence is high in Asian.
  • 11. Course Natural course of disease is Variable:-  May be relatively stable  May repeated bleeding and leakage with vision loss and chorioretinal atrophy  With or without fibroitic scarring  Reddish- orange nodules alone or nodule and small sub- retinal hemorrhage and absence of hard exudates.  May association with other condition like thrombocytopenia and massive hemorrhage has been reported  Also association with sickle cell disease and irradiation.
  • 12. Clinical feature Usually bilateral  Protruding orange –red elevated lesion often with nodular elevations of RPE.  Also described as –  Polypoidal lesion ,polyp like or grasp like  Association serous exudation and hemorrhage , that may lead to detachment of the RPE and sometimes neurosensory retina  Sometime associated features recurrent hemorrhage and vitreous hemorrhage.
  • 13. Clinical feature (contd) Location of the lesion:  In the macular area -69.5%  Under the temporal retinal vascular arcade 15%  Peripapillary area (within one disc diameter of disc edge -4.5%.  Also mid peripheral area
  • 14. Clinical feature (contd)Lesions may active or inactive. • Lesions considered as active on the evidence of clinical, OCT, FFA any one of the following: 1. Vision loss of 5 or more letters (ETDRS chart) 2. Subretinal fluid with or without intraretinal fluid. 3. PED 4. Subretinal hemorrhage or fluorescence leakage.
  • 15. ICGA :- • Accepted as the gold standared for diagnosis of PCV. • Better visualization in ICGA than FFA  ICG absorbs and emit near infrared light, which readily penetrates the RPE and enhancing veiwing of choroidal lesions  ICG binding affinity with plasma proteins, that means – it does not leak from chorio-capillaries in the same way as fluorescence, so choroidal lesions are less obscured.
  • 16. Characteristics feature of PCV in ICGA:-  A branching network of inner choroidal vessels.  Nodular polypoidal aneurysm or dilations at the edge of these abnormal vessels network, which correspond to orange sub-retinal nodules.  Presence of single or multiple focal nodular areas of hyperfluorescence arising from choroidal circulation within the first 6 minutes
  • 17. Classification According to Japanese group on PCV Quiescent: Polyps in the absence of subretinal or intraretinal fluid or hemorrhage. Exudative : Exudation without hemorrhage, which may include sensory retinal thickening, Neuro-sensory retinal detachment, PED, subretinal lipid exudation. Hemorrhagic: Any hemorrhage with or without other exudative characteristics
  • 18. Differential Diagnosis  AMD  CSCR
  • 19. Treatment Thermal laser Photocoagulation: To be beneficial ,albeit it with short term follow up and for extra foveal lesion. In some studies  Improve and stabilize vision- in 55-100%  Vision loss – in 13-45%  Whole lesion compared with polyps only appears to be more efficacious.
  • 20. Photodynamic therapy:  Regression or resolution of the polyp by in angio occlusive mechanism of action  Restrict loss of letters on ETDRS chart to less than 15 letters or improved vision 80-100% patient after 1 year.
  • 21. Anti VEGF therapy:  Intravitreal Ranibizumab resolving the macular oedema, polypoidal complexes decreased in 4/12 (33%) eyes.  Intravitreal Bevacizumab 1/11 (9.09%) eyes
  • 22. Combination therapy:  Both combination therapy and vertiporfin PDT monotherapy superior to ranibizumab monotherapy in achieving complete polyp regression at 6 months.  Improvement in BCVA and central retinal thickness also favored combination therapy.
  • 23. THANK YOU